Bayer completed a US$44.9 million investment for corporate offices in Mexico City. Stephan Gerlich, president of the Company in Mexico, underscored that temporary issues will not cloud the long term vision the Company has for this Country. Mexico has received investment valued at US$224 million over the last five years. The new building will be used to house the Pharmaceuticals and Corp Science divisions, along with the previous buildings that make up the corporate complex of Bayer Mexico.

Login to Digital Content

POPULAR TAGS

Subscribe to our Newsletter Bulletin